{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T14:45:21Z","timestamp":1781102721029,"version":"3.54.1"},"reference-count":17,"publisher":"Japanese Society for Pediatric Endocrinology","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Pediatr Endocrinol"],"published-print":{"date-parts":[[2021]]},"DOI":"10.1297\/cpe.30.133","type":"journal-article","created":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T18:08:50Z","timestamp":1625854130000},"page":"133-137","source":"Crossref","is-referenced-by-count":5,"title":["20p11.23-p11.21 deletion in a child with hyperinsulinemic hypoglycemia and GH          deficiency: A case report"],"prefix":"10.1297","volume":"30","author":[{"given":"Daisuke","family":"Sugawara","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Saitama Medical Center Jichi              Medical University, Saitama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misa","family":"Matsuura","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Saitama Medical Center Jichi              Medical University, Saitama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Saitama Medical Center Jichi              Medical University, Saitama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Ohashi","sequence":"additional","affiliation":[{"name":"Division of Medical Genetics, Saitama Children\u2019s              Medical Center, Saitama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ko","family":"Ichihashi","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Saitama Medical Center Jichi              Medical University, Saitama, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"125","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Thompson-Branch,                A,              Havranek,            T. Neonatal            hypoglycemia. Pediatr Rev          2017;38: 147\u201357.","DOI":"10.1542\/pir.2016-0063"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Dayem-Quere,                M,              Giuliano, F,                Wagner-Mahler,              K, Massol,                C,                Crouzet-Ozenda,              L, Lambert,                JC, et al.            Delineation of a region responsible for panhypopituitarism in            20p11.2. Am J Med Genet A          2013;161A: 1547\u201354.","DOI":"10.1002\/ajmg.a.35921"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Vajravelu,                ME, Chai,                J, Krock,                B, Baker,                S, Langdon,                D, Alter,                C, et al.            Congenital hyperinsulinism and hypopituitarism attributable to a mutation            in FOXA2. J Clin Endocrinol Metab          2018;103: 1042\u20137.","DOI":"10.1210\/jc.2017-02157"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Yorifuji,                T,              Horikawa, R,                Hasegawa,            T, Adachi,                M, Soneda,                S,              Minagawa, M,              et al. (on behalf of The Japanese Society for            Pediatric Endocrinology and The Japanese Society of Pediatric Surgeons).            Clinical practice guidelines for congenital            hyperinsulinism. Clin Pediatr Endocrinol          2017;26: 127\u201352.","DOI":"10.1297\/cpe.26.127"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Williams,                PG,                Wetherbee,              JJ,              Rosenfeld,            JA, Hersh,                JH. 20p11            deletion in a female child with panhypopituitarism, cleft lip and palate, dysmorphic            facial features, global developmental delay and seizure disorder.            Am J Med Genet A          2011;155A: 186\u201391.","DOI":"10.1002\/ajmg.a.33763"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Garcia-Heras,                J, Kilani,                RA, Martin,                RA, Lamp,                S. A deletion            of proximal 20p inherited from a normal mosaic carrier mother in a newborn with            panhypopituitarism and craniofacial dysmorphism. Clin            Dysmorphol          2005;14: 137\u201340.","DOI":"10.1097\/00019605-200507000-00006"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Kamath,              BM, Thiel,                BD, Gai,                X, Conlin,                LK, Munoz,                PS,                Glessner,            J, et al.            SNP array mapping of chromosome 20p deletions: genotypes, phenotypes, and            copy number variation. Hum Mutat          2009;30: 371\u20138.","DOI":"10.1002\/humu.20863"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Giri,              D, Vignola,                ML,                Gualtieri,              A,              Scagliotti,            V, McNamara,                P, Peak,                M, et al.            Novel FOXA2 mutation causes hyperinsulinism, hypopituitarism with            craniofacial and endoderm-derived organ abnormalities. Hum Mol            Genet          2017;26: 4315\u201326.","DOI":"10.1093\/hmg\/ddx318"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Heddad                Masson, M,                Poisson, C,                Gu\u00e9rardel,              A, Mamin,                A,              Philippe, J,                Gosmain,            Y. Foxa1 and            Foxa2 regulate \u03b1-cell differentiation, glucagon biosynthesis, and            secretion. Endocrinology          2014;155: 3781\u201392.","DOI":"10.1210\/en.2013-1843"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Stanley,                CA.            Perspective on the genetics and diagnosis of congenital hyperinsulinism            disorders. J Clin Endocrinol Metab          2016;101: 815\u201326.","DOI":"10.1210\/jc.2015-3651"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Yorifuji,                T, Masue,                M,                Nishibori,              H. Congenital            hyperinsulinism: global and Japanese perspectives. Pediatr            Int          2014;56: 467\u201376.","DOI":"10.1111\/ped.12390"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Tsai,              EA,                Grochowski,              CM, Falsey,                AM,                Rajagopalan,              R, Wendel,                D, Devoto,                M, et al.            Heterozygous deletion of FOXA2 segregates with disease in a family with            heterotaxy, panhypopituitarism, and biliary atresia. Hum            Mutat          2015;36: 631\u20137.","DOI":"10.1002\/humu.22786"},{"key":"13","doi-asserted-by":"publisher","unstructured":"13. Kale,              T, Patil,                R, Pandit,                R. A Newborn            with panhypopituitarism and seizures. Case Rep Genet          2017;2017: 4364216. 10.1155\/2017\/4364216.","DOI":"10.1155\/2017\/4364216"},{"key":"14","doi-asserted-by":"publisher","unstructured":"14. Dines,              JN, Liu,                YJ,                Neufeld-Kaiser,              W, Sawyer,                T, Ishak,                GE, Tully,                HM, et al.            Expanding phenotype with severe midline brain anomalies and missense            variant supports a causal role for FOXA2 in 20p11.2 deletion syndrome.            Am J Med Genet A          2019;179: 1783\u201390.          10.1002\/ajmg.a.61281.","DOI":"10.1002\/ajmg.a.61281"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Pirttil\u00e4,                TJ,                Manninen,            A, Jutila,                L,              Nissinen, J,                K\u00e4lvi\u00e4inen,              R, Vapalahti,                M, et al.            Cystatin C expression is associated with granule cell dispersion in            epilepsy. Ann Neurol          2005;58: 211\u201323.","DOI":"10.1002\/ana.20545"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Binder,              G, Weber,                K, Rieflin,                N,                Steinruck,              L,                Blumenstock,              G, Janzen,                N, et al.            Diagnosis of severe growth hormone deficiency in the            newborn. Clin Endocrinol (Oxf)          2020;93: 305\u201311.","DOI":"10.1111\/cen.14264"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Ding,              YQ, Marklund,                U, Yuan,                W, Yin,                J, Wegman,                L, Ericson,                J, et al.            Lmx1b is essential for the development of serotonergic            neurons. Nat Neurosci          2003;6: 933\u20138.","DOI":"10.1038\/nn1104"}],"container-title":["Clinical Pediatric Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/cpe\/30\/3\/30_2020-0074\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T23:55:12Z","timestamp":1625874912000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/cpe\/30\/3\/30_2020-0074\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1297\/cpe.30.133","relation":{},"ISSN":["0918-5739","1347-7358"],"issn-type":[{"value":"0918-5739","type":"print"},{"value":"1347-7358","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]},"article-number":"2020-0074"}}